Latest Caris Life Sciences Stories
Additional Etiology Research Demonstrates Clinical Utility of Caris Molecular Intelligence in Identifying Molecular Targets for Guiding Treatment Strategies IRVING, Texas, May 31,
Paired Tumor Research in Glioma, Breast Cancer and Epithelial Ovarian Carcinoma Guides Clinical Application of Comprehensive Tumor Profiling IRVING, Texas, May 30, 2015 /PRNewswire/
ASCO Presentations Highlight Therapeutic Implications of Similar Genetic Landscape for Brain Metastases in NSCLC, Breast Cancer and Melanoma, as well as Similarities and Differences Between Endometrial,
ASCO Presentations Highlight Therapeutic Implications of PD-1/PD-L1 Expression and Interaction with Signaling Pathways in Patients with Colorectal and Pancreatic Cancers IRVING, Texas,
ASCO Presentations Showcase Utility of Caris Molecular Intelligence in Cataloging Disease Biomarkers in Gastrointestinal, Hepatic, Gynecologic and Renal Cancer Subtypes IRVING, Texas, May 29,
ASCO Presentations Shed Light on Biomarkers for Rare and Resistant GIST Subtypes and for Triple Wild-type Melanoma IRVING, Texas, May 28, 2015 /PRNewswire/ -- Caris Life Sciences,
Caris Molecular Intelligence Tumor Profiling Data Presented at ASCO Highlights Drug Efflux Pump Expression and PIK3CA Pathway Aberrations from 50,000 Tumors and 20,000 Tumors Respectively
IRVING, Texas, May 27, 2015 /PRNewswire/ -- Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced it has appointed
Virginia Cancer Specialists Joins Caris Centers of Excellence for Precision Medicine Network to Help Develop Guidelines and Standards of Care for Tumor Profiling IRVING, Texas, May
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.